👏 👏

🙏 WWTF & the jury for funding. We look forward to working with AmberMed and our stakeholders @stadtwien.bsky.social Austrian Public Health Institute (GÖG), AIDS Hilfe Wien, Dachverband der österr. Sozialversicherungen, Intl. Vaccine Institute, Österr. Gesundheitskasse @feantsa.bsky.social ECO. 8/8

What do we pledge? We leverage academic and practical knowledge with lived experience of all involved participants to deliver a policy blueprint supported by cutting-edge scientific & societal results. Follow us for more! Official project start & project website: March `25. 7/n

AmberMed is the biggest healthcare provider for people without #HealthInsurance in Austria where vaccine uptake, disease awareness, and #cancer #prevention are particularly important. Also: people without insurance are often excluded from existing datasets. 6/n

Experts in transdisciplinarity & pathogen evolution (Orsolya Molnar, Bethany Dearlove, @andreasbergthaler.bsky.social), social science & medicine (@lislehner.bsky.social @grabovacigor.bsky.social), epidemiology & simulation (Niki Popper) will work w/ patients at @diakonieat.bsky.social AmberMed. 5/n

A complex challenge requires a diverse team of experts to work closely with patients from marginalised groups. Our project #HPVienna integrates all stakeholders into a groundbreaking #transdisciplinary framework delivering #genomic, #social, #modelling and #societal outcomes. 4/n

There are many HPV genotypes, and different types carry different cancer risks. #Vaccines covering up to 9 types are available, however #access and #uptake has historically been restricted by age, gender and geography. Tracking HPV types is important to understand impact. 3/n

#HPV associated diseases are a large #PublicHealth issue: as the most prevalent #STI 80% of people will get infected over their lifetime. Most cases clear within 2 years, but 10% of infections persist and may cause #cervicalcancer, #headandneckcancer or other #cancer types. 2/n